Literature DB >> 11319979

Successful treatment of molluscum contagiosum with topical imiquimod in a severely immunocompromised HIV-positive patient.

R M Strauss1, E L Doyle, A H Mohsen, S T Green.   

Abstract

Molluscum contagiosum is a common viral infection in the immuno-compromised HIV-positive patient where it is often severe and affecting the face and neck. It is frequently resistant to conventional, locally destructive therapies. Anecdotal evidence suggests that the immunomodulatory drug imiquimod might be a valid therapeutic option in this group of patients. We report the case of a severely immunocompromised HIV-positive patient with resistant facial molluscum contagiosum lesions that responded to topical imiquimod. The response to therapy and the possible implications for pathogenesis are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11319979     DOI: 10.1258/0956462011922832

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

Review 1.  Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.

Authors:  Antona J Wagstaff; Caroline M Perry
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Disseminated molluscum contagiosum in a HIV-positive child. Improvement after therapy with 5% imiquimod.

Authors:  Martin Theiler; Werner Kempf; Katrin Kerl; Lars E French; Günther Fl Hofbauer
Journal:  J Dermatol Case Rep       Date:  2011-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.